Two new clinical trials aimed at treating Alzheimer’s disease are starting up at Barrow Neurological Institute.

Even one fall by an older adult is just as accurate in predicting cognitive decline as individuals with elevated amyloid, the Alzheimer's brain protein considered the gold standard for gauging ...

Scientists have developed a blood test that could predict Alzheimer's symptoms years in advance using p-tau217 protein levels ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a ...

Researchers have developed a diagnostic panel that identifies cognitive decline by analyzing how blood proteins fold. This ...

Alzheimer's disease researchers say they've built a method using simple blood tests to predict if and when someone may show ...

A study of 470,000 people reveals that the APOE gene could be behind 90% of Alzheimer's cases in the world today.

While further validation will be required, these findings suggest that plasma p-tau217 clocks could provide a practical and ...

Alzheimer’s disease and related dementias were less likely among adults who completed cognitive speed training with booster sessions, according to data published in Alzheimer’s & Dementia: ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...